Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
23 Febbraio 2021 - 1:00PM
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage
biopharmaceutical company developing a pipeline of novel drug
candidates against validated molecular targets in indications of
high unmet medical need, announced today that it will present
at two upcoming investor conferences in March:
Cowen 41st
Annual Health Care
ConferenceDate: Tuesday, March 2,
2021Time: 9:10 – 9:40 a.m. ET
Barclays Global Healthcare
ConferenceDate: Tuesday, March 9,
2021Time: 4:45 – 5:10 p.m. ET
Webcast information for these events will be
accessible on the Events page under the Investor Relations section
of the Applied Therapeutics website at www.appliedtherapeutics.com.
A replay will also be available following the webcast.
About Applied Therapeutics
Applied Therapeutics is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates against
validated molecular targets in indications of high unmet medical
need. The Company’s lead drug candidate, AT-007, is a novel central
nervous system penetrant aldose reductase inhibitor (ARI) for the
treatment of Galactosemia, a rare pediatric metabolic disease. The
Company initiated a pivotal Phase 1/2 clinical trial in June 2019,
read out positive top-line biomarker data in adult Galactosemia
patients in January 2020 and announced full data from the trial in
April 2020. The Company is also developing AT-001, a novel potent
ARI that is being developed for the treatment of Diabetic
Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The Company
initiated a Phase 3 registrational study in DbCM in September 2019.
The preclinical pipeline also includes AT-003, an ARI designed to
cross through the back of the eye when dosed orally, for the
treatment of diabetic retinopathy, as well as novel dual PI3k
inhibitors in preclinical development for orphan oncology
indications.
Investors:Maeve Conneighton(212) 600-1902
orappliedtherapeutics@argotpartners.com
Media:Gleb
Sagitovmedia@appliedtherapeutics.com
Grafico Azioni Applied Therapeutics (NASDAQ:APLT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Applied Therapeutics (NASDAQ:APLT)
Storico
Da Lug 2023 a Lug 2024